These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27806071)
1. Fosfomycin Addition to Poly(D,L-Lactide) Coating Does Not Affect Prophylaxis Efficacy in Rat Implant-Related Infection Model, But That of Gentamicin Does. Gulcu A; Akman A; Demirkan AF; Yorukoglu AC; Kaleli I; Bir F PLoS One; 2016; 11(11):e0165544. PubMed ID: 27806071 [TBL] [Abstract][Full Text] [Related]
2. Rifampicin-fosfomycin coating for cementless endoprostheses: antimicrobial effects against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). Alt V; Kirchhof K; Seim F; Hrubesch I; Lips KS; Mannel H; Domann E; Schnettler R Acta Biomater; 2014 Oct; 10(10):4518-24. PubMed ID: 24948548 [TBL] [Abstract][Full Text] [Related]
3. Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Lucke M; Wildemann B; Sadoni S; Surke C; Schiller R; Stemberger A; Raschke M; Haas NP; Schmidmaier G Bone; 2005 May; 36(5):770-8. PubMed ID: 15794930 [TBL] [Abstract][Full Text] [Related]
4. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Schmidmaier G; Lucke M; Wildemann B; Haas NP; Raschke M Injury; 2006 May; 37 Suppl 2():S105-12. PubMed ID: 16651063 [TBL] [Abstract][Full Text] [Related]
5. Gentamycin delivered from a PDLLA coating of metallic implants: In vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. Vester H; Wildemann B; Schmidmaier G; Stöckle U; Lucke M Injury; 2010 Oct; 41(10):1053-9. PubMed ID: 20541756 [TBL] [Abstract][Full Text] [Related]
6. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Alt V; Bitschnau A; Osterling J; Sewing A; Meyer C; Kraus R; Meissner SA; Wenisch S; Domann E; Schnettler R Biomaterials; 2006 Sep; 27(26):4627-34. PubMed ID: 16712926 [TBL] [Abstract][Full Text] [Related]
7. Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat model. Fölsch C; Federmann M; Kuehn KD; Kittinger C; Kogler S; Zarfel G; Kerwat M; Braun S; Fuchs-Winkelmann S; Paletta JR; Roessler PP Int Orthop; 2015 May; 39(5):981-8. PubMed ID: 25380688 [TBL] [Abstract][Full Text] [Related]
8. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Lucke M; Schmidmaier G; Sadoni S; Wildemann B; Schiller R; Haas NP; Raschke M Bone; 2003 May; 32(5):521-31. PubMed ID: 12753868 [TBL] [Abstract][Full Text] [Related]
9. Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats. Diefenbeck M; Schrader C; Gras F; Mückley T; Schmidt J; Zankovych S; Bossert J; Jandt KD; Völpel A; Sigusch BW; Schubert H; Bischoff S; Pfister W; Edel B; Faucon M; Finger U Biomaterials; 2016 Sep; 101():156-64. PubMed ID: 27294535 [TBL] [Abstract][Full Text] [Related]
10. Systemic antibiotic therapy does not significantly improve outcome in a rat model of implant-associated osteomyelitis induced by Methicillin susceptible Staphylococcus aureus. Fölsch C; Federmann M; Lakemeier S; Kuehn KD; Kittinger C; Kerwat M; Fuchs-Winkelmann S; Paletta JR; Roessler PP Arch Orthop Trauma Surg; 2016 Apr; 136(4):585-92. PubMed ID: 26873243 [TBL] [Abstract][Full Text] [Related]
11. A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses. Neut D; Dijkstra RJ; Thompson JI; Kavanagh C; van der Mei HC; Busscher HJ Eur Cell Mater; 2015 Jan; 29():42-55; discussion 55-6. PubMed ID: 25552428 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats. Poeppl W; Lingscheid T; Bernitzky D; Schwarze UY; Donath O; Perkmann T; Kozakowski N; Plasenzotti R; Reznicek G; Burgmann H Antimicrob Agents Chemother; 2014 Sep; 58(9):5111-6. PubMed ID: 24936591 [TBL] [Abstract][Full Text] [Related]
13. In vivo quantification of gentamicin released from an implant coating. Nast S; Fassbender M; Bormann N; Beck S; Montali A; Lucke M; Schmidmaier G; Wildemann B J Biomater Appl; 2016 Jul; 31(1):45-54. PubMed ID: 26865659 [TBL] [Abstract][Full Text] [Related]
14. Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits. Liu D; He C; Liu Z; Xu W Int J Nanomedicine; 2017; 12():5461-5471. PubMed ID: 28814863 [TBL] [Abstract][Full Text] [Related]
15. In vitro testing of a first-in-class tri-alkylnorspermidine-biaryl antibiotic in an anti-biofilm silicone coating. Ashton NN; Allyn G; Porter ST; Haussener TJ; Sebahar PR; Looper RE; Williams DL Acta Biomater; 2019 Jul; 93():25-35. PubMed ID: 30769135 [TBL] [Abstract][Full Text] [Related]
16. The antimicrobial activity and biocompatibility of a controlled gentamicin-releasing single-layer sol-gel coating on hydroxyapatite-coated titanium. Nichol T; Callaghan J; Townsend R; Stockley I; Hatton PV; Le Maitre C; Smith TJ; Akid R Bone Joint J; 2021 Mar; 103-B(3):522-529. PubMed ID: 33641411 [TBL] [Abstract][Full Text] [Related]
17. Local delivery of linezolid from poly-D,L-lactide (PDLLA)-linezolid-coated orthopaedic implants to prevent MRSA mediated post-arthroplasty infections. Kaur S; Harjai K; Chhibber S Diagn Microbiol Infect Dis; 2014 Jul; 79(3):387-92. PubMed ID: 24809862 [TBL] [Abstract][Full Text] [Related]
18. Vitamin E Phosphate Coating Stimulates Bone Deposition in Implant-related Infections in a Rat Model. Lovati AB; Bottagisio M; Maraldi S; Violatto MB; Bortolin M; De Vecchi E; Bigini P; Drago L; Romanò CL Clin Orthop Relat Res; 2018 Jun; 476(6):1324-1338. PubMed ID: 29771856 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus. Poeppl W; Tobudic S; Lingscheid T; Plasenzotti R; Kozakowski N; Georgopoulos A; Burgmann H Antimicrob Agents Chemother; 2011 Feb; 55(2):931-3. PubMed ID: 21098253 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of gentamicin palmitate against high concentrations of Staphylococcus aureus. Kittinger C; Marth E; Windhager R; Weinberg AM; Zarfel G; Baumert R; Felisch S; Kuehn KD J Mater Sci Mater Med; 2011 Jun; 22(6):1447-53. PubMed ID: 21556977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]